Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
US9820977B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2009 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | May 22, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P33/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutically acceptable single parasiticidal agent compositions of imidacloprid for oral delivery to mammals to systemically control targeted blood-sucking or blood-consuming parasites, such as fleas, ticks and certain species of helminthes and scabies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.